New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of …
by Rick Glover
Filed under Arthritis Books
New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of …
LUND, SWEDEN–(Marketwire – 04/15/10) – - Enhanced levels of brain derived neurotrophic factor, possibly contributing to neuroprotection, were shown in laquinimod treated multiple sclerosis (MS) patients – Laquinimod significantly reduce demyelination and axonal damage as shown in animal models – Two ongoing pivotal, global phase III clinical trials are fully enrolled and results are anticipated …
Read more on Marketwire via Yahoo! Finance
